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Abstract A close association between pain, depression
anddisabilityhasbeenshown.However,theneurometabolic
correlatesofthisassociationhavebeenbarelyinvestigatedin
disease states. Episodic cluster headache is a severe head-
ache syndrome and represents a suitable disease model for
the investigation of episodic pain. The aim of this study was
toexploretherelationshipbetweendepressionanddisability
as well as pain scores and brain metabolism in patients with
cluster headache during the disease period with repetitive
pain attacks, but outside an acute attack. Thirteen patients
with cluster headache underwent 2-[ﬂuorine-18]-ﬂuoro-2-
deoxy-D-glucose positron emission (FDG-PET) and com-
pleted questionnaires on depression and disability as well as
a pain visual analogue rating scale (VAS). A positive cor-
relation between the depression scores and glucose metab-
olism was observed in the insular cortex. A positive
correlation between the pain disability scores and brain
metabolismwasdetectedintheamygdala.Thesameapplied
to the pain visual analogue rating scores. Our data underline
theassociationbetweensevereepisodicpain,depressionand
disability. In addition to this clinical observation, our results
stress the importance of the insula and amygdala in pain
processing and suffering.
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Abbreviations
SVcorrected Small volume corrected
FWE Family wise error
Introduction
Brain correlates of experimental pain have been exten-
sively investigated by modern imaging techniques such as
functional magnetic resonance imaging (fMRI) and posi-
tron emission tomography (PET) [2, 58]. Pain is a complex
sensory phenomenon with many different aspects which
have been investigated using those techniques. Most of
these imaging studies used paradigms with laser, contact
heat [8, 78] or electrical stimulation [16, 38] to provoke
pain. Another possibility is the topical application of cap-
saicin [45, 54]. However, experimentally induced pain as a
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DOI 10.1007/s00415-010-5704-3model for clinical pain is limited because of the side effects
of the stimulation procedure itself, e.g., burns due to
stimulation temperatures above 50C. Hence, extremely
severe pain can not be evoked in humans under experi-
mental conditions for ethical and safety reasons. Thus, the
investigation of long-term mood alterations or disability,
especially in the context of severe repetitive pain attacks or
chronic pain, is problematic. However, the relevance and
high prevalence of depression and disability has been
documented for every facet of clinical pain in many studies
[47] and also in primary headache syndromes [7, 11, 27].
Depression and impaired quality of life are highly
important variables in pain research because of their com-
plexinteractionswithpainandviceversa[11,24].Notonlya
clinical [32], but also a neurometabolic overlap between
depression and pain has been hypothesized [30]. However,
the neurometabolic correlates of depressionand disabilityin
severe pain syndromes have been barely investigated so far.
Cluster headache (CH) is a primary headache disorder
with attacks typically recurring in bouts. The duration of
the attacks varies between 15 and 180 min and the attacks
are associated with a variety of cranial autonomic symp-
toms [74]. The pain is usually restricted to one side of the
face and conﬁned to the orbital, supraorbital and temporal
regions [34]. A strong circadian periodicity with attacks
often occurring at night is another hallmark of the disorder
[60]. CH is very disabling with a high individual and
socioeconomic burden, especially during periods of fre-
quent attacks [35]. Because of the excruciating pain
attacks, CH has also been called suicide headache [75].
In this study, we investigated patients suffering from CH
as a clinical model for severe episodic pain and aimed to
determine brain areas in which the metabolism relates to the
burdenofdepressivesymptoms,disabilityandpainintensity
using a correlative approach with 2-[ﬂuorine-18]-ﬂuoro-2-
deoxy-D-glucose positron emission tomography (FDG-
PET).
Materials and methods
Patients
Thirteen male patients with strictly side-locked episodic
cluster headache (mean age 44.2 years, SD 8.89) with no
other prediagnosed neurological or psychiatric disease were
included in the study. The patients indicated an average
attack duration of 103 min and an average frequency of 2.5
attacks per day. The mean duration of their cluster headache
bouts was 16 weeks. The study was approved by the local
ethicscommitteeaswellastheGermanRadiationProtection
Commission,andconformswiththeDeclarationofHelsinki.
All participants gave written informed consent after a
detailed explanation of the procedures. All patients met the
criteria of the International Headache Society (IHS) for
episodic cluster headache conﬁrmed by two neurologists
specialized in headache. The PET scans were acquired dur-
ing the period with repetitive cluster headache attacks (‘‘in
bout’’), but without acute pain during the scanning. The last
attack occurred 6 h or more before the PET scanning to
ascertain that patients were interictal. At the time of scan-
ning, the patients were in the bout period (repetitive pain
attacks) for at least 1 week. Due to the severity of the
headache syndrome, all patients were allowed to continue
the use of their prophylactic medication. Eight patients were
taking verapamil, one patient lithium, one patient a combi-
nation of lithium and verapamil, one patient ergotamine and
two patients had no prophylactic medication. Clinical mag-
neticresonanceimagingofthebrainwasunremarkableinall
patients. Some of the patient data were previously included
in a study of our group comparing the brain metabolism in
cluster headache patients with the metabolism in healthy
volunteers [68].
Data acquisition and preprocessing
All study participants were imaged using FDG-PET in three-
dimensional mode with septa retracted on a Siemens ECAT
EXACTHR ? Scanner(CTI,Knoxville,TN,USA).Aneck-
shield (NeuroShield, Scanwell Systems, Lavigne St. Mon-
treal, Canada) was used to reduce random count rates. The
patients were positioned with the head parallel to the cant-
homeatal line within the gantry. An antecubital vein cannula
was used to administer the tracer as an i.v. bolus (185 MBq
18F-FDG for each scan). During the scanning, all subjects
restedandhadtheireyesclosed.Asequenceofthreeframesof
10 min each was started and afterwards combined into a
single frame. After attenuation correction by a standard
ellipse-ﬁtting method, the PET data were reconstructed by
ﬁlteredbackprojectionwithaHammﬁlter(cut-offfrequency
0.5cycles/projectionelement)into60imageplanesandintoa
128 9 128 pixel image matrix (pixel size 2.1 9 2.1 mm).
As CH is a strictly lateralized headache syndrome [34],
the PET scans of the patients with left-sided headache
(n = 6)weremirroredintheaxialplanetobeabletoanalyse
all cluster headache patients as one group. Thereafter, all
images were transformed into standard stereotactic space
(Talairach space) by linear scaling and non-linear warping
using the NEUROSTAT program [51, 52]. Normalization
was performed with NEUROSTAT instead of the statistical
parametric mapping software (SPM), because the latter
program does not provide a FDG template, and normaliza-
tionofFDGdatatotheH2
15O-PETtemplateofSPMhasbeen
shown to be inaccurate [28]. Spatial smoothing was per-
formed with a Gaussian kernel of 8 mm full width at half
maximum (FWHM).
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123Questionnaires
The participants were instructed to ﬁll out the following
questionnaires directly before injection of the radioactive
tracer and the PET scanning:
CES-D
The Center for Epidemiological Studies Depression Scale
(CES-D) has been frequently used to assess depressive
symptoms in the general population. This is also true for its
German version [61]. It is part of the German pain ques-
tionnaire, which has been compiled by the German chapter
of the International Association for the Study of Pain [56],
and is the most widely used instrument to measure
depressive symptoms in the context of episodic or chronic
pain in Germany. The CES-D generates a total score
ranging from 0 to 60. Scores C16 indicate clinically sig-
niﬁcant levels of depressive symptoms. At this cut-off, the
sensitivity is 100% and the speciﬁcity is 88% for a major
depressive disorder [6, 62]. The CES-D includes items
about the frequency of depressive symptoms, including
somatic symptoms and interference with interpersonal
interactions, experienced during the past week. Positive
and negative experiences are indicated on a 4-point Likert
scale: 0 = Rarely or None of the Time (Less than 1 day),
1 = Some or Little of the Time (1–2 days), 2 = Occa-
sionally or Moderate Amount of the Time (3–4 days), and
3 = Most or All of the Time (5–7 days). The CES-D total
score is typically generated by summation of the individual
item scores. Four items assess the presence of positive
feelings and are rated inversely.
Pain disability index
The Pain Disability Index (PDI) is a measure of pain-
related disability, assessing perceived impairment of
functioning across seven areas of daily functioning. The
PDI asks subjects to rate the degree to which chronic pain
interferes with activities in each of the domains: family/
home responsibilities, recreation, social activity, occupa-
tion, sexual behavior, self-care, and life-supporting activi-
ties. The total range is 0–70 points with higher scores
indicating more perceived disability [79]. The PDI is an
internally consistent (a = 0.86) measure of perceived dis-
ability with good concurrent, criterion-related and dis-
criminative validity in a variety of inpatient and outpatient
pain populations [59, 71, 72].
VAS-rating
We used a VAS rating scale (0–10) for pain ratings [14],
which provides a scale for the subjective assessment of the
pain intensity and consists of a straight line, the limits of
which carry a verbal description of each extreme of the
symptom to be evaluated (no pain and unbearable pain).
Patients were instructed to indicate their average perceived
pain intensity of the cluster headache attacks during the last
attacks of the preceding month. As indicated above, the
patients were out of an attack at the time of the scanning.
Statistics
Questionnaire data
Correlations between the scores of the separate question-
naires were calculated with the Spearman Rho test.
P\0.05 was considered to be signiﬁcant.
Statistical parametric mapping analysis/correlation
analysis
Brain metabolism was correlated with psychophysical data
as previously described [20, 65, 73]. Covariation analyses
of scans and CES-D scores, as well as PDI and VAS scores,
were conducted with SPM2 (Wellcome Department of
Imaging Neuroscience, London, UK) using MATLAB 6.5
(Mathworks Inc., Sherborn, MA, USA). We expected
covariation of the psychophysical scores with the metab-
olism in brain regions that have been previously shown to
be involved in pain processing (thalamus, S1, S2, insula,
amygdala, anterior cingulate cortex, parietal and prefrontal
cortex) [2, 58] and the covariation analyses were conﬁned
to these regions. The resulting maps of t statistics were
transformed to the unit normal distribution and thresholded
at P\0.001, uncorrected, for all contrasts. The minimal
cluster extension (number of adjacent signiﬁcant voxels)
was set at 15 contiguous voxels passing the statistical
threshold. Small volume correction using the family-wise
error (FWE) approach (P\0.05) was applied on the pre-
speciﬁed regions (spherical volumes of interest with a
radius of 10 mm surrounding the activation center).
We also conducted subgroup covariation analyses
excluding the patients on lithium therapy as lithium has
been previously shown to alter the brain metabolism. These
subgroup analyses were conducted in an identical way as
described for the whole group of patients.
Results
Clinical/behavioural data
The mean duration of the bout before the FDG-PET
investigation was 8 weeks with a standard deviation (SD)
of 4 weeks. The mean of the VAS pain ratings for the last
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1234 weeks was 9.42 (SD 0.78), the mean PDI score was 33.31
(SD 19.5) and the mean CES-D score was 23 (SD 9.77).
All but three of the patients had CES-D scores above the
cut-off value of 16, indicating a signiﬁcant level of
depressive symptoms. There were no statistically signiﬁ-
cant correlations between the different scores/scales (e.g.,
between VAS and PDI). CES-D scores as well as PDI
scores did not correlate with the duration of the bout.
Follow-up CES-D scores ‘‘out of bout’’ in ﬁve of the
patients indicated no depressive symptoms out of bout [the
mean CES-D score out of bout was 5.6 (SD 5.1)].
FDG-PET correlation with PDI and VAS
We found a covariation of the FDG-PET signal and the
subjective pain perception (VAS) and disability scores
(PDI) in different subregions of the amygdala (P\0.001).
The brain metabolism in the laterobasal amygdaloid group
(LB) was correlated with the VAS pain ratings, whereas a
correlation with the PDI scores was found in the superﬁcial
group (SF) of the amygdala (Figs. 1, 2). The sites of
covariation within the amygdala were lateralized (contra-
lateral to the side of the cluster headache) for the VAS pain
scores, but bilateral for the PDI scores. When lowering the
signiﬁcance level (P\0.005), an additional trend of
covariation (VAS scores) was observed in the ipsilateral
amygdala.
The P values and the statistical peak coordinates are
listed in Table 1. The correlation coefﬁcient was r = 0.807
when correlating the PDI scores and r = 0.647 when cor-
relating the VAS scores with the FDG-PET signal in the
amygdala at the local statistical peak (Spearman
correlation).
The voxel-wise covariation analysis excluding the
patients on lithium provided very similar results as com-
pared to the analysis of the whole group. Covariation was
again seen bilaterally in the amygdala for the PDI scores (x/
y/z coordinate 29/16/-29; z score 4.84; P\0.001; cluster
extension 239 voxels and x/y/z coordinate -9/-7/-25;
z score 4.61; P\0.001; cluster extension 191 voxels) and
unilaterally for the VAS scores (x/y/z coordinate -20/
-5/-20; z score 4.61; P\0.001; cluster extension 147
voxels).
FDG-PET correlation with CES-D
The covariation analysis of CES-D scores and the FDG-
PET signal yielded correlations in the anterior/middle
insular cortex on the side contralateral to the cluster
headache symptoms (corrected P value = 0.027;
Fig. 1 Correlation analysis of VAS pain scores (yellow) and PDI
scores (red) with FDG-PET signal thresholded at P\0.001. The
statistical parametric maps are overlaid on a skull stripped normalized
structural magnetic resonance image (MRI) in axial planes (average of
27 T1-weighted scans of the same individual from the Montreal
Neurological Institute) as provided by the MRICRO program package
(http://www.sph.sc.edu/comd/rorden/mricro.html). The MRI was ste-
reotactically normalized with NEUROSTAT before overlay
Fig. 2 Correlation analysis of CES-D with FDG-PET signal, thres-
holded at P\0.001. The statistical parametric map is overlaid on a
skull stripped normalized structural magnetic resonance image (MRI)
in axial planes (average of 27 T1-weighted scans of the same
individual from the Montreal Neurological Institute) as provided by
the MRICRO program package (http://www.sph.sc.edu/comd/rorden/
mricro.html). The MRI was stereotactically normalized with NEU-
ROSTAT before overlay
Table 1 Statistical results of the covariation analysis of the FDG-
PET data and PDI as well as VAS scores
Amygdala Cluster-
size
Voxel level xy z
ZP uncorrected PSVcorrected
(FWE)
PDI 147 4.80 \0.001 \0.001 27 14 -32
4.60 \0.001 0.001 18 2 -32
31 4.13 \0.001 0.004 -90 -20
VAS 88 4.49 \0.001 0.001 -18 -2 -18
P values and centers of gravity for the signiﬁcant clusters in the
amygdala are indicated. The coordinates for the peak correlations are
stated in Talairach space
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123z score = 3.64; peak x/y/z-coordinate -34/14/7; number of
contiguous signiﬁcant voxels: 24 voxels).
The correlation coefﬁcient was r = 0.858 for the cor-
relation between CES-D scores and the FDG-PET signal in
the insular cortex (Fig. 3).
When lowering the signiﬁcance level (P\0.01,
uncorrected), an additional trend of covariation (CES-D
scores) was observed in the ipsilateral anterior/middle
insular cortex and the sub-/perigenual ACC.
In the subgroup analysis excluding the patients on lith-
ium therapy, the location of the covariation peak with the
CES-D scores was almost identical as compared to the
analysis of the whole patient group (x/y/z coordinate -32/
14/7; z score 3.56; P\0.001; cluster extension 18).
Discussion
We present FDG-PET data on episodic CH as a disease
model for severe episodic pain and correlate these PET
data with scores of pain intensity, the CES-D and PDI.
Glucose is the major substrate for brain metabolism, and
FDG-PET is, therefore, suitable for measuring the glucose
metabolic pattern and detecting changes in local synaptic
activity [63]. Correlation of brain metabolism with neuro-
psychological test scores is an approach to map underlying
neuropsychological processes [20, 65, 73]. In contrast to
methods recording short term changes in the context of
pain processing, like fMRI or H2
15O PET, our approach
focuses on prolonged changes in brain metabolism related
to the repeated experience of severe pain, and these
changes may be conceived as neuroplastic adaptations,
leading to increased brain activity and glucose metabolism
in speciﬁc regions [33].
As indicated above, patients continued their prophylac-
tic medication. Because of the excruciating nature of CH, it
seemed unethical to ask the patients to stop their medica-
tion with the risk of worsening their headache frequency
and severity. Theoretically, the medication, notably lith-
ium, may impact the FDG metabolism. However, only two
patients were on lithium at the time of scanning and the
results were unchanged in the analysis with exclusion of
these two patients. Moreover, lithium related changes in
brain activity have been reported for the dorsomedial
frontal cortex, cerebellum and lingual cortex [41], but not
for any region observed to correlate with psychometric data
in our study. As regards verapamil, no verapamil-induced
changes in brain metabolism have been reported thus far in
the literature. Altogether, we believe that the results are
valid as we studied the patients while they were on their
typical medication; thus, in the most naturalistic setting.
Hence, the results reﬂect the metabolic substrates of
depression, pain intensity and disability in patients as they
are seen in clinical practice.
PET correlation with pain intensity and disability
The average VAS pain score of more than nine out of ten
for the CH attacks during the previous 4 weeks illustrates
the severity of CH and the usefulness of this disorder as a
clinical model for severe episodic pain. It is intuitive that
pain of such an intensity is accompanied by relevant psy-
chophysiological symptoms, serious impairment of daily
life, and disability. The PDI scores indicate such a severe
disability in multiple aspects of life [15]. The observation
that pain ratings and PDI scores are highly correlated with
amygdalar metabolism can be regarded as evidence for a
common psychophysiological basis of perceived pain
intensity, and disability (PDI) represented in the amygdala.
Regarding the PDI, this can be best explained by the
convergent validity of this score with anxiety scores [50].
Amygdalar function and anatomy
As part of the limbic system, the amygdala is involved in
emotional processing, including the evaluation of sensory
information as pleasant or aversive [31]. The consolidation
of memories of emotionally arousing experiences such as
fear or disgust is also represented in the amygdala [49, 55].
Anatomical studies have suggested the presence of an
intrinsic system of GABAergic neurons that acts as an
interface between sensory afferents and brain stem-pro-
jecting neurons [13]. However, the human amygdala is no
homogeneous anatomical structure [4]. Based on differ-
ences in cyto- and chemoarchitecture, it can be differenti-
ated into the laterobasal amygdaloid group (LB), the
centromedial group (CM), and the superﬁcial group (SF)
[1]. Results from previous neuroimaging studies [40, 80]
suggest functional differences in the human amygdala
Fig. 3 Spearman correlation of the adjusted FDG-PET signal in the
insula and the CES-D scores; r = 0.858
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123similar to those of the animal amygdala, whereupon the LB
is believed to play a crucial role in assigning emotional
value to sensory stimuli [64]. The CM receives convergent
information from other amygdaloid regions and sends
efferent information to various subcortical structures,
generating behavioural responses such as the modulation of
autonomic activity [21, 43, 44]. The function of the SF has
not been satisfactorily investigated so far in humans, but
animal studies showed an involvement of this subregion in
affective processing [29]. Response differences between
LB, SF, and CM, have not been directly assessed in human
functional neuroimaging studies so far, and speciﬁc func-
tional properties of these subdivisions of the human
amygdala are, therefore, unclear [4].
Pain and amygdala
The role of the amygdala in human pain processing is
only partly understood. Bilateral lesions of the amygdala
in monkeys cause reductions of opioid and cannabinoid
induced antinociception [46]. This has been supported by
the observation that experimental pain stimuli induce
endogenous opioid release in the amygdala [67, 69, 81].
Responses to painful stimuli with a strong affective
component have previously been reported in the amygdala
[66], and a study investigating the lateralization of amy-
gdalar activations in response to laser induced pain has
shown symmetric activations [9]. We found an ipsilateral
correlation of pain intensity ratings and amygdalar
metabolism, but there was an additional contralateral
trend, and our ﬁndings are, therefore, similar to the
ﬁndings of the noted previous study with experimental
pain stimulation [9], supporting the concept of bilateral
amygdalar responses.
The ﬁnding of pain intensity coding in the amygdala is
in agreement with a previous parametric fMRI study
investigating amygdalar responses to experimentally
induced painful stimuli of different intensities. In this
study, Bornhovd et al. [10] showed a dependency of the
amygdalar activation state and the intensity of the painful
stimuli. As we found no correlation of pain intensity with
typical sensory brain regions belonging to the lateral pain
system, such as the primary or secondary somatosensory
cortex, our data indicate that the amygdala may be par-
ticularly relevant in the intensity coding of clinical pain.
In our study, pain scores were correlated with the
metabolism of the LB, whereas the PDI scores were linked
to the SF, and although one has to be cautious regarding the
spatial discrimination of different statistical maxima in
small brain areas such as the amygdala in PET studies, our
results suggest a differential correlative pattern of glucose-
metabolism and pain intensity versus disability within the
amygdala.
Correlation between CES-D scores and PET data
The CES-D scores indicate a clinically relevant depressive
state during the bout period and are, therefore, suitable to
investigate the relationship between pain associated
depression and glucose metabolism [6]. The Center for
Epidemiological Studies Depression Scale applied in this
study has been previously used not only in clinical pain
medicine,buthasalsobeenappliedrepetitivelyinfunctional
imaging studies [23, 57] and population studies [37]. It has
been suggested that in pain patients, the CES-D has a better
sensitivity than the Beck Depression Inventory (81.8 vs.
68.2%), and both questionnaires were shown to be able to
discriminate between persons with and without major
depression [26].
In a previous study on episodic cluster headache, none of
thepatientsmetdiagnosticcriteriaforamooddisorderduring
the period preceding a bout. During the bout, however, the
averageHamiltonDepressionRatingScale(HDRS)scorewas
8.6, which was higher than in a control group of tension type
headache patients with an average score of 6.5, although the
difference was not statistically signiﬁcant [36]. HDRS scores
between zero and seven are generally accepted to be within
normal limits [25], and the scores in the cluster headache
patients were somewhat higher than what is considered to be
normal. Moreover, the authors acknowledged that the study
design may have led them to underestimate the frequency of
depressive disorders. This supports the view that depressive
symptoms occur ‘‘in bout’’, whereas no such symptoms are
evident‘‘outofbout’’—justlikeinourpatientcohort.Another
recent study reported Hamilton depression scores of eight or
greater in 43% of chronic cluster headache patients [22]a n d
we believe that it is conceivable that also shorter bouts of
excruciating head pain, such as in episodic cluster headache,
canproducetransientalterationsofmoodandbehaviour[76].
Considering our results and the results of the noted previous
studies,itmaybeusefultoconsiderpainrelateddepressionin
a comprehensive treatment concept of CH.
A correlation of CES-D scores and glucose metabolism
was present in the insular cortex and, as a trend, also in the
sub-/perigenual ACC. However, there was no covariation
of depression scores with the neurometabolism in other
parts of the brain thought to play a role in the pathogenesis
of depression such as the prefrontal cortex [42, 48].
Insular cortex
The insular cortex is among the most frequently reported
brain regions in neuroimaging studies on pain [77]. In pri-
mates, the insular cortex has numerous connections with the
cerebral cortex, the basal ganglia and limbic structures [3].
The anterior and mid-insula are known to be active in
response to a wide variety of somatic stimuli, including
128 J Neurol (2011) 258:123–131
123tactile [5, 17], vibratory [18], innocuous thermal [19], ol-
factogustatory[19],andpain[12,18,53,78]anditsfunction
can be regarded as an interface between viscerosensory
information preparation and its subliminal and conscious
processing.
An increase of insular metabolism and a normalization
after treatment of a major depressive disorder with SSRIs
has been observed [39]. These authors suggested that
suppression of insular activity may be necessary for the
recovery from depression. Moreover, increased insular
activation has been shown in patients with major depres-
sion as compared to healthy controls when anticipating
painful stimuli [70]. It was inferred that the anticipatory
brain response indicates hypervigilance to threats and
might lead to maladaptive modulation of pain [70].
Taken together, our results stress the importance of the
amygdala and insula in pain processing and suffering. The
results also suggest that the insular glucose metabolism
may predict depressive symptoms in episodic pain.
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